Introduction
The cell-autonomous enzymatic degradation of nuclear DNA (chromatinolysis) is a hallmark of apoptosis (Hengartner, 2000; Wyllie, 284 ) and presumably constitutes an important mechanism designed to avoid the transfer of mutated DNA from tumor cells (which may contain gain-of-function mutations of oncogenes) to surrounding healthy cells (de la Taille et al., 1999; Bergsmedh et al., 2001; Bergsmedh et al., 2002) . Much of the oligonucleosomic 'ladder-type' DNA degradation is due to the activation of caspase-dependent DNAse (CAD) Sakahira et al., 1998) . However, caspase-independent mechanisms of apoptotic DNA degradation are well described (Montague et al., 1994; Montague et al., 1997; Dumont et al., 2000; Susin et al., 2000; Li et al., 2001; Widlak et al., 2001; Wyllie and Golstein, 2001; Wang et al., 2002) .
Apoptosis-inducing factor (AIF) is a flavoprotein with NADH oxidase activity normally contained in the mitochondrial intermembrane space (Susin et al., 1999; Miramar et al., 2001; Klein et al., 2002) . Upon apoptosis induction, AIF translocates from mitochondria to the cytosol and to the nucleus . During early nuclear condensation, AIF is found to be associated with chromatin (Ye et al., 2002) . AIF protein binds to DNA and causes purified nuclei to undergo chromatin condensation, DNA degradation to B50 kbp fragments and DNA loss (Susin et al., 1999; Ye et al., 2002) . The knock out of the AIF gene indicates that AIF participates in the first wave of caspase-independent morphogenetic cell death, required for cavitation of embryoid bodies in in vitro differentiation cultures (Joza et al., 2001) . In addition to acting in the early ontogeny of apoptosis, AIF is a phylogenetically ancient factor . Thus, AIF homologs undergo a mitochondrio-nuclear translocation during cell death occurring in the slime mold Dictyostelium discoideum (Arnoult et al., 2001) and in the nematode Caenorhabditis elegans .
Although the mitochondrial release of AIF is controlled by caspases in some models (Arnoult et al., 2002) , it is caspase-independent in several important paradigms of apoptosis induction. Thus, DNA damage can induce the caspase-independent AIF release either through p53 (Cregan et al., 2002) , or via PARPmediated NAD depletion (Yu et al., 2002) . AIF is also released in several in vivo models of anoikis (Hisatomi et al., 2001) , HIV-1 infection , and ischemia/reperfusion (Blomgren et al., 2003) , even in conditions in which caspases are suppressed. Once released from mitochondria, AIF acts in a caspaseindependent fashion as this has been shown in several experimental systems including in C. elegans . Additional caspase-independent enzymes that have been suggested to participate in apoptotic chromatinolysis include endonuclease G Wang et al., 2002) , DNAse I (Widlak et al., 2001) , and cyclophilins (Montague et al., 1994; Montague et al., 1997) .
The exact molecular mechanisms through which AIF induces chromatin remodeling and degradation have been elusive, and until now the only proteins known to interact with AIF are members of the heat shock protein 70 (HSP70) family, which actually act as AIF inhibitors . Apparently, the apoptogenic activity of AIF does not depend on its NADH oxidase activity. Chemical inactivation of the flavine adenine nucleotide (FAD) moiety required for AIF redox activity does not block its apotogenic function in cellfree systems , and mutations that destroy the FAD binding site do not affect the apoptogenic function of AIF in transfection assays (Loeffler et al., 2001) . Rather, mutation of amino-acid residues required for DNA binding (but not for redox activity) abrogate the apoptogenic potential of AIF in the cell-free system as well as in intact cells (Ye et al., 2002) . In C. elegans, AIF reportedly cooperates with endonuclease G , a DNAse that also undergoes a mitochondrio-nuclear translocation process . However, no such evidence has been obtained in the mammalian system, where endonuclease G appears to cooperate with DNAse I (Widlak et al., 2001) .
Intrigued by these incognita, we decided to explore the mechanism through which AIF induces DNA degradation. Here, we report that AIF can cooperate with cyclophilin A (CypA) to induce chromatinolysis both in vitro and in vivo.
Results and discussion
Physical interaction between AIF and CypA as determined by mass spectroscopy, pull down assays, coimmunolocalization, coimmunoprecipitation, and deletion mapping Mass spectrometry of proteins retained on an AIF affinity column led to the identification of a peptide sequence (N-SIYGEKFEDENFILK-C) corresponding to peptidyl-prolyl cis-trans isomerase A (also called cyclophilin A, CypA, SwissProt accession code P10111). Since cyclophilins may participate in apoptotic DNA degradation and can induce large-scale DNA fragmentation (Montague et al., 1994; Montague et al., 1997) , as does AIF (Ye et al., 2002) , we decided to investigate the physical and functional interaction between CypA and AIF. CypA is normally localized both in the cytosol and in nuclei, while AIF is confined to mitochondria (Susin et al., 1999) (Figure 1) . In control cells, thus AIF and CypA did not colocalize, as determined by confocal immunofluorescence microscopy. However, upon induction of apoptosis, for instance with staurosporin (STS), AIF and CypA colocalized in defined areas of the nucleus. This phenomenon was mainly observed in cells with peripheral (stage I) chromatin condensation and was not inhibited by the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD.fmk) (Figure 1 ), which however prevented the progression of nuclear apoptosis from stage I to stage II, that is from a peripheral and partial to a more pronounced chromatin condensation with formation of apoptotic bodies . AIF and CypA exhibited no coimmunoprecipitation in nonapoptotic Jurkat cells (Figure 2a) . However, addition of STS or serum withdrawal (marked as 'FCS À '), two apoptosisinducing conditions which stimulate the mitochondrial release of AIF into the cytosol and its translocation into the nucleus (Susin et al., 1999; Joza et al., 2001) , led to a significant increase in the AIF/CypA interaction, as determined by coimmunoprecipitation (Figure 2a ). Recombinant AIF and recombinant CypA were found to interact in pull-down assays (Figure 2b ), indicating that the interaction between the two proteins is bona fide direct (and does not require the concourse of additional proteins or other macromolecules such as DNA). Recombinant AIF, tagged either with a V5 epitope or a green fluorescent protein (GFP) moiety, produced by in vitro transcription/translation also coimmunoprecipitated with CypA contained in cellular extracts (Figure 2c ). Deletion of amino acids (aa) 367-466, 269-442, or 263-399 abolished the interaction between AIF and CypA. Thus, the CypA interaction domain is located within (or close to) a stretch of B30 amino acids (367-399) of AIF, which is different from its HSP70 interacting domain (aa 150-228) Gurbuxani et al., 2003) and from its DNA-binding sites (aa 255/265 and aa 510/518) (Ye et al., 2002) . Accordingly, a molar excess of Hsp70 or DNA failed to block the AIF-CypA interaction (Figure 2d ). Addition of cyclosporin A, which inhibits the peptidyl-prolyl cistrans isomerase activity of CypA had no effect on the AIF/CypA interaction (Figure 2d ), which thus occurs independently of its chaperone function.
Molecular modeling of the CypA-AIF interaction
The notion that AIF interacts with CypA through a novel interaction domain was confirmed by molecular modeling. An optimal model of docking between CypA and AIF (see Materials and methods) indicates that CypA and AIF establish extensive molecular contacts ( Figure 3a) . AIF contributes to the interface with one of its a-helices (P345-R358) and several b-strands (V361-N366, T328-F334, R387-A397) and turns (E359-G360, A367-S371, K382-G386) that form together a b-sheet bulge. CypA contributes to the interface with one of its two a-helices (M136-G146), the following turn and b-strand (S147-G150), as well as part of its central bbarrell (R55-Q63, H92-A101, Q111-T119). The predicted interface is stabilized by several molecular interactions ( Figure 3b ). D385 on the AIF model is Hbonded to both K151 and S153 on the CypA structure. The side chain of R387 on AIF is involved in H-bonds with the backbone atoms of both R144 and G146 on CypA. Another hydrogen bond is made between the backbone atoms of K388 and N149. The side chain of R148 on CypA establishes a salt bridge with the side chain of E329 and an additional H-bond with the backbone atoms of E390. Moreover, P58 on CypA exhibits close packing with the side chain of K362 on AIF, while a larger hydrophobic patch includes the side chains of R148 on CypA and the ones of M364 and Pull-down assay using recombinant AIF and CypA proteins. Recombinant proteins were coincubated (rAIF plus rCypA) and then AIF was immunoprecipitated to detect CypA by immunoblot. As a control, in the sole presence of CypA, the AIF-specific antibody fails to precipitate CypA. (c) Pull-down assay and mapping of the interaction site. V5 epitope-(left panel) or GFPtagged (right panel) AIF constructs (or b-Gal and GFP alone) were translated in vitro, mixed with cell extracts, followed by pull-down of V5-tagged (left) or GFP-tagged (right) proteins and their detection by the indicated antibodies. (d) Failure of Hsp70, CsA, and DNA to inhibit the AIF-CypA interaction. In vitro translated V-5-tagged b-Gal or AIF were exposed to control cytosol of Hsp70-containing cytosol, followed by pull-down as in (b). In addition, the pull-down assay was done in the presence of excess amounts of CsA or DNA. Results are representative of three independent experiments V389. The analysis of the electrostatic and lipophilic potential for the two proteins highlighted a good physicochemical complementarity at the predicted interface. Importantly, the predicted interface does not reduce the accessibility to the catalytic site of CypA, to the predicted binding site of Hsp70, and the DNAbinding site on the AIF model, in accord with the fact that cyclosporin A (CsA) and HSP70 fail to inhibit the CypA-AIF interaction in pull-down experiments (Figure 2d ).
Obligate cooperation between AIF and CypA to induce DNA degradation in isolated nuclei and purified DNA Nuclei from healthy, nonapoptotic cells exposed to recombinant AIF protein in a cell-free system manifest a reduction of the DNA content to a subdiploid level (Susin et al., 1997; Lorenzo et al., 2000) . CypA itself had no such effect. However, the combination of AIF and CypA was much more potent in inducing nuclear chromatinolysis than either AIF or CypA alone ( Figure  4a,b) . Thus, AIF and CypA can cooperate to induce nuclear apoptosis in vitro. Since it has been suggested that CypA has a latent nuclease activity (Montague et al., 1994; Montague et al., 1997) , we investigated whether recombinant AIF and CypA, alone or combined, may digest naked supercoiled plasmid DNA in vitro. While AIF had no such effect alone, it did cause DNA digestion in the presence of CypA (Figure 4c ), in a fashion that was not inhibited by CsA (not shown). In our assay conditions, CypA alone had no or little DNAse activity in the absence of AIF (sixth lane in Figure 4c ). The combination of AIF and CypA led to the generation of a smear of DNA, indicating a nonspecific pattern of DNA degradation. Altogether, these data indicate that AIF cooperates with CypA to produce an active DNA-degrading enzyme.
AIF and CypA cooperate to induce DNA degradation in intact cells
To demonstrate that the AIF-CypA interaction is relevant to the apoptogenic action of AIF, we took advantage of Jurkat cells that had been engineered to (Figure 5a ). Moreover, we found consistently, in seven independent experiments, that transfection of a full-length AIF-GFP fusion construct (which sensitizes to apoptosis Ye et al., 2002) did increase the frequency of STS-treated apoptotic CypA þ / þ Jurkat cells but not that of CypA À/À cells (Figure 5b ). The relative apoptosis resistance of CypA À/À cells correlated with a reduced level of large-scale DNA fragmentation to B50 kbp (Figure 4b ), a type of DNA fragmentation that is, at least in part, dependent on AIF Susin et al., 2000) . Importantly, the difference in apoptosis susceptibility between CypA þ / þ and CypA À/À cells disappeared when the expression of AIF was reduced using small interfering RNA (siRNA) specific for AIF (Figure 5c ), although the reduction of AIF levels did not affect the expression of CypA (Figure 5d ). Altogether, these data indicate that CypA and AIF cooperate in apoptotic DNA degradation. To further substantiate the CypA-AIF cooperation, we analysed a series of AIF mutants designed to lose interaction with CypA ( Figure 2c ) and evaluated their apoptosissensitizing potential upon transient transfection of (Figure 5a ), underscoring the functional importance of the CypA-AIF interaction. Upon transfection into Jurkat cells, these AIF mutants lacking the CypA interaction domain (D269-442, D263-399) were as inefficient as another deletion mutation affecting the C-terminus strictly required for the AIF-mediated induction of subdiploidy (D567-609) or a DNA-binding domain (D473-552) (Ye et al., 2002) . As a side observation, we found that a mutation affecting another, more N-terminal putative DNA-binding domain (D153-342) (Ye et al., 2002) did not reduce the AIF-mediated chromatinolysis, suggesting a functional hierarchy among the DNA-binding domains of AIF. Irrespective of this result, our data suggest that the CypA interaction domain of AIF is important for its apoptogenic action. In a further series of experiments, AIF was transfected into CypA À/À cells either alone or together with a cDNA coding for CypA. In this set-up, the combined tranfection of CypA and AIF resulted in the generation of apoptotic cells having a subdiploid DNA content, while either CypA or AIF alone had no such effect (Figure 6b) . A CypA active site mutant (H126Q) that loses its peptidyl-prolyl cis-trans isomerase activity (Ansari et al., 2002) was as efficient as wildtype CypA in cooperating with AIF (Figure 5b ). The combination of AIF-GFP plus CypA (or CypA H126Q), transfected into CypA-deficient (CypA À/À ) cells, was as efficient in apoptosis induction as the transfection of AIF-GFP alone into CypA-sufficient (CypA þ / þ ) cells (Figure 6b ). Altogether, these data demonstrate that AIF and CypA synergize to induce nuclear apoptosis, and that this cooperation involves the CypA-binding domain of AIF, yet does not require the isomerase activity of CypA.
Concluding remarks
In the present paper, we show that the caspaseindependent death effector AIF can participate in the degradation of nuclear DNA, in accord with the following scenario. Once liberated from mitochondria, AIF translocates to the nucleus, provided that it is not retained in the cytosol by an interaction with Hsp70 . In the nucleus, it undergoes electrostatic interactions with DNA and tethers CypA to chromatin (Ye et al., 2002) . Formation of such a trimolecular complex (CypA/AIF/DNA) is possible because the DNA-and CypA-binding domains of AIF are distinct. The AIF/CypA complex then causes DNA degradation. Although clearcut genetic and biochemical evidence supports this scenario, the AIF/CypA interaction cannot be the only one that determines the AIFmediated regulation of cell death. Indeed, the knockout or knockdown of AIF causes developmental defects with supernumerary cells, either in mouse embryonic stem cells differentiated in vitro (Joza et al., 2001) or in C. elegans . However, the knockout of CypA does not induce major teratogenic effects, at least in the mouse (Colgan et al., 2000) , indicating that during embyronic development the apoptogenic function of CypA may be compensated by other proteins, perhaps by structurally related cyclophilins. Irrespective of these considerations, however, the data shown here reveal that AIF can cooperate with CypA in chromatinolysis. This cooperation occurs independently from the well-described, CsA-inhibitable peptidyl-prolyl cis-trans isomerase activity of CypA. CypA thus joins the club of phylogenetically ancient proteins endowed with a dual, Janus-like function in life and death.
Materials and methods

Cells and culture conditions
Jurkat cells (either CypA
) were cultured in RPMI1640 medium supplemented with 10% fetal calf serum (FCS), L-glutamine, and antibiotics, as described (Braaten and Luban, 2001) . Cells were treated with STS (200 nM, 16 h) and/ or Z-VAD.fmk (100 mM, Bachem, Torrance, CA, USA), or deprived from serum (72 h) to induce cell death. Large-scale DNA fragmentation was assessed by pulse field gel electrophoresis . Apoptosis was detected using a panel of published methods (Castedo et al., 2002) .
Mass spectrometric identification of AIF-binding proteins
Recombinant AIF was immobilized on SHA Sepharose s resin (Invitrogen, Carlsbad, CA, USA). Triton-soluble proteins contained in rat brain extracts (Marzo et al., 1998) were retained on these columns, eluted on an NaCl gradient beyond 500 mM NaCl and concentrated by buffer exchange, as described in detail by Gurbuxani et al. (2003) . The proteins were denatured, reduced, alkylated, subjected to proteolysis with trypsin, and then identified by LC-MS/MS (Spahr et al., 2000; Gurbuxani et al., 2003) .
Immunoprecipitation and pull-down assay AIF was immunoprecipitated from sonicated cellular extracts (1 mg/ml) resuspended in IP buffer (50 mM HEPES pH 7.6, 150 mM NaCl, 5 mM EDTA, 0.1 NP-40), using an mAb raised against aa 101-300 of AIF (E1, Santa Cruz, CA, USA), with protein A Sepharose (Amersham, Buckinghamshire, England), and prepared for immunoblotting as described . HisV5 or GFP-tagged AIF mutants were translated in vitro using a reticulocyte lysate system (Promega) and incubated with total HeLa cell extract in IP buffer, followed by pull-down of V5 or GFP with suitable antibodies (Invitrogen), and immunoblot detection of CypA (rabbit antiserum, Affinity Bioreagents), as described Schmitt et al., 2003) . This experiment was also performed in the presence of cytosol from Hsp70-overexpressing cells , CsA(10 mM, Novartis) or purified total human genomic DNA (1 mg/ml) added to the HeLa cell extract and present throughout the pull-down procedure. In addition, the recombinant proteins rAIF (1 mg/ ml) and rCypA (500 ng/ml) were immunoprecipitated in IP buffer using rabbit polyclonal AIF (1/50) (Susin et al., 1999) .
Molecular modeling
The three-dimensional structure coordinate files of human CypA (Ke, 1992) were downloaded from the Protein Data Bank (Berman et al., 2000) . The theoretical model of human AIF (Ye et al., 2002) was built using comparative modeling techniques as previously described . Protein-protein docking was accomplished employing 3D_Dock (Aloy et al., 1998 ). An angular deviation of 91 and electrostatic filtering for the total space sampling were applied. The resulting complexes were sorted according to surface complementarity and electrostatic score values. An empirical scoring of the complexes, using residue level pair potentials (Aloy et al., 1998) , was also performed. The protein interfaces obtained were then optimized using the Multidock program (Jackson et al., 1998) . Molecular properties such as electrostatic potentials were calculated using DelPhi and visualized with GRASP . Noncovalent interactions on AIF and CypA were evaluated using the 'dry' probe within GRID package (Goodford, 1985) . Additionally, the complexes were filtered for the presence of specific amino acids (i.e. residues 367-399 belonging to the AIF model) in the predicted interface. The best model displaying some of those amino acids in the interface with CypA was ranked as fifth in the overall scoring procedure. The best four complexes predicted by 3D_Dock are very similar among them. Here, CypA binds to a long loop (P544-Y560) on the homology-built model of AIF. Owing to the inherent uncertainty in a loop structure generated by modeling, the complexes involving this loop were not considered further.
Transfection and siRNA
Jurkat cells were transfected with the pcDNA3.1 vector expressing enhanced GFP alone (Invitrogen), or different AIF constructs fused at their C-terminus to GFP (Loeffler et al., 2001) , alone or in combination with a cDNA-encoding wild-type or active site mutant (H126Q) CypA (Ansari et al., 2002 ), using Lipofectamin 2000 . After 24 h (15% GFP-positive cells), cells were stimulated with STS (200 nM, 16 h). The frequency of cells with a subdiploid DNA content was determined by fixing the cells in 70% ethanol overnight at 41C followed by staining with DAPI (15 mM, 15 min) and cytofluorometric analysis (Lorenzo et al., 2000) .
Knockdown of AIF by siRNA
For downregulation of AIF expression, Jurkat cells were transfected with a siRNA double-stranded oligonucleotide designed to interfere with the expression of human AIF (sense strain: 5 0 GAUCCUCCCCGAAUACCUCTT-3 0 , Proligo, Boulder, CO, USA), using an electroporation procedure (0.25 kV, 960 mFd, 80-120 ms) with a BioRad Gene Pulser equipment (Marne-la-coquette). As a control, we used an oligoncucleotide designed to downregulate mouse AIF (sense strain: 5 0 AUGCAGAACUCCAAGCACGTT-3 0 ), which does not affect human AIF.
Immunofluorescence
Cells grown on coverslips were fixed with paraformaldehyde (4% w : v) plus picric acid (0.19% v : v) in PBS (Castedo et al., 2001) . Cells were then stained for the detection of AIF (polyclonal goat antiserum D20 from Santa Cruz) or CypA (rabbit antiserum, Affinity Bioreagents), revealed with suitable anti-IgG conjugates (donkey anti-goat Alexa 568 and antirabbit Alexa 488 from Molecular Probes); and counterstained with Hoechst 33342.
Cell-free system of nuclear apoptosis and DNA degradation Purified HeLa nuclei (Lorenzo et al., 2000) were exposed to recombinant mouse AIF protein (Susin et al., 1999) and/or to recombinant human CypA (Calbiochem) in CFS buffer (Lorenzo et al., 2000) for 2 h at 371C, followed by staining with propidium iodine (PI) and cytofluorometric assessment of the frequency of nuclei with a subdiploid DNA content (Lorenzo et al., 2000) . Purified bacterial plasmid (pcDNA3.1, 25 mg/ml) was incubated first with CypA in 20 nM TrisHCl pH 8.0, 1 mM MgCl2 and 1 mM CaCl2 (Montague et al., 1997) and then with variable doses of AIF at 371C for 1 h.
Abbreviations AIF, apoptosis-inducing factor; BSA, bovine serum albumin; Cyp-A, cyclophilin A; Cyt c, cytochrome c; FCS, fetal calf serum; Hsp70, heat shock protein 70; Hsc70, heat shock cognate protein 70; STS, staurosporin; Z-VAD.fmk, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone.
